about
Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shockRole of prothrombin complex concentrate in perioperative coagulation therapyTransfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion.Guidelines for the use of platelet transfusions.Massive transfusion and coagulopathy: pathophysiology and implications for clinical management.Perioperative platelet transfusion: recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS) 2003.The coagulopathy of massive transfusion.Moderate plasma dilution using artificial plasma expanders shifts the haemostatic balance to hypercoagulation.Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS).Coagulation factors V, VIII, and X, prothrombin time and activated partial thromboplastin time test results in thawed plasma stored at 1-6 ºC for 5 days.Optimizing the use of blood products in trauma care.Postpartum hemorrhage in developing countries: is the public health community using the right tools?Femoral nailing-related coagulopathy determined by first-hit magnitude: an animal study.Management of major trauma haemorrhage: treatment priorities and controversies.How we manage the haematological aspects of major obstetric haemorrhage.A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage.Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype.Resuscitating PROPPRly.Recombinant activated factor VII decreases bleeding without increasing arterial thrombosis in rabbits.A practical guideline for the haematological management of major haemorrhage.Postauthorization safety study of Clottafact® , a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study.Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes.[Procedure for critical nonsurgical bleeding].[Coagulopathy in multiple trauma: new aspects of therapy].
P2860
Q26861501-69C6E6F8-E510-4584-B635-C7F28B0C6BE8Q26863536-F284DEDC-5CFD-4465-8EF4-2A9AE24BB810Q30635705-6B08272F-AC7A-462E-988E-78E0B77FC3B5Q33348675-3FD36903-158B-447E-9BA2-F84E1D41755CQ33360283-E6FFDC36-B6DC-4C62-80A5-FD954E8BDD13Q33364338-63D88453-282C-4EDD-AA91-21A1922345E0Q33368314-C551EA32-D445-4869-ADD8-A79FD96857B6Q33678363-B5F67251-9732-457A-8D0A-6D671169FDF4Q34334830-941A88EB-1104-4104-B770-FEE634DCB17BQ34492809-A72A4C37-1FB8-4C55-AA61-C06AA8370A22Q35578932-F65590EA-3AE7-466C-8E7D-5D6C79146422Q35775543-D4CDEB1F-19E6-42C3-8AEA-1C1BA6E34F27Q36825845-B80D35AA-D361-45B8-BD20-07F8B83266BCQ37948114-DE56998C-F18A-4175-AE2B-5AFAFB7BEC7CQ38175202-6366DD2E-21E4-45BA-B0BA-B6A7645CEFCDQ39000420-F4AC2037-A85E-4846-BFAC-09907AE67EB6Q39176846-30132FEC-1B1C-4337-806A-C44868B38BC7Q41096308-5EFB858F-A682-4528-8388-0D2CBA35FE50Q45017994-8B94392F-B40F-4B38-B927-9FFA940DDE41Q45877402-0ACC029A-FE6B-4F53-BD4D-05BB1FB90CDBQ47313093-9439F424-9150-4C90-906B-C8E1E49940E6Q50512736-33D095B3-F8F9-45DE-9DCA-04DFBB5CB993Q50707061-F521CCC3-F998-4AF0-ADDA-087E18773D40Q50708976-05EF1FD2-9251-4E86-9766-32C682F59387
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Replacement of massive blood loss.
@ast
Replacement of massive blood loss.
@en
type
label
Replacement of massive blood loss.
@ast
Replacement of massive blood loss.
@en
prefLabel
Replacement of massive blood loss.
@ast
Replacement of massive blood loss.
@en
P2860
P1433
P1476
Replacement of massive blood loss.
@en
P2093
Hiippala S
P2860
P304
P356
10.1111/J.1423-0410.1998.TB05449.X
P478
74 Suppl 2
P577
1998-01-01T00:00:00Z